Merck KGaA, Roche deal

MRK's Biovation Ltd. unit (Aberdeen, U.K.) will apply its DeImmunisation technology to undisclosed ROCZ targets. DeImmunisation technology is designed to eliminate or reduce T cell responses. Biovati...